Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT-2s

February 2016

More warnings for the SGLT2 inhibitors (Invokana, etc) will increase concerns about their safety.

These "flozins" are popular because they have a low risk of hypoglycemia...lead to modest weight loss...and can lower BP.

Plus Jardiance (empagliflozin) has CV benefits including a reduced risk of cardiovascular death and heart failure hospitalizations.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Antithrombotics Don't Delay Restarting Anticoagulation in Atrial Fib Patients After GI Bleeding
Heart Failure Prevent Med-Related Problems to Reduce Heart Failure Readmissions
Diabetes Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT-2s
Diabetes Suggest New Glucose Meter Technology For the Tech Savvy
Neurology & Pain Don't Jump to Buprenorphine Before Non-Opioids for Chronic Pain
Fall Risk Caution About Falls with SELECTIVE Alpha-blockers
Vaccines Give injections in the right spot to avoid shoulder injuries
Cough & Cold Avoid ORAL Phenylephrine
Hepatitis C Be Aware of Possible Liver Failure with Holkira Pak or Technivie
Acne Reassess Acne Treatments After 2 or 3 Months
Women's Health Don't Shun All SSRIs During Pregnancy
Hyperkalemia Suggest Low-Cost Treatments for High Potassium